The present disclosure provides methods comprising administering to the individual an effective amount of an agent that decreases or inhibits TIGIT expression and/or activity and an anti cancer agent and/or an anti cancer therapy. Further provided are kits comprising an anti cancer agent an agent that decreases or inhibits TIGIT expression and/or activity or both as well as instructions for use thereof.